Biocon wins MYR 300 mn contract for Insulin from Malaysia
Biocon Ltd announced that the Ministry of Health (MoH), Malaysia, has awarded a three year contract, to its subsidiary, Biocon […]
Say something
Wednesday
April
Upcoming Event
Biocon Ltd announced that the Ministry of Health (MoH), Malaysia, has awarded a three year contract, to its subsidiary, Biocon […]
Biocon Ltd announced that the U.S.Food and Drug Administration has accepted Mylans biologics license application for MYL- 1401O. Dr Arun […]
Biotech major Biocon today announced that European Medicines Agency (EMA) has accepted for review Mylan’s marketing authorisation application for their biosimilar […]
Biocon has launched advanced novel therapy for the treatment of Hepatitis C at a lower price. CIMIVIR-L, a fixed dose […]
Biocon opens a facility to manufacture devices for its insulin portfolio. The facility is said to be spread over 10,000 […]
Kiran Mazumdar Shaw, Biocon Chairman and Managing Director, has been elected as the first non-executive Chairman of Association of Biotechnology […]
EDITORIAL Innovation is full of life COVER STORY Innovations Spurring in Indian Health IT ZOOM IN The Visionaries Look for Healthcare Solutions […]
The Department of Information Technology, Bio-Technology and Science & Technology, Government of Karnataka, Vision Group on Biotechnology and MM Activ […]
EHR EHRs among top technology priorities for health care utives Electronic health records are among thetop 10 technologies that health […]
Biocon the Biopharma major is planning to set up an academic institution called Biocon Academy next financial year.
The world’s top drug maker Pfizer said that it has entered into a deal to sell drug maker Biocon Ltd’s biosimilar versions of diabetes treatment insulin.
Biocon, India’s largest biotechnology company, entered into an agreement with Teleradiology Solutions, a pioneer of the domain in India, to provide teleradiology reporting services to Clinigene, Biocon’s Clinical Research Organisation.
Bangalore based biotechnology major Biocon has recorded a profit of 81 crores this quarter.
Enter your email to receive a weekly round-up of our best posts.